Searched for
NEPHRO CARE SHARES
Public-private projects key to expand access to Kidney care: NephroPlusNephroPlus, India's leading provider of dialysis services, is on a mission to reshape the future of kidney health with an innovative tech-b...- NephroPlus gets Sebi nod to launch IPO, to raise Rs 353 crore from fresh issueDialysis services leader Nephrocare Health Services, operating under NephroPlus, has received Sebi’s approval to launch its IPO, comprising...
- IPO-bound NephroPlus scales operations to 500 clinics, across India, Nepal, Philippines, UzbekistanIPO-bound NephroCare Health Services on Wednesday said it has scaled its operations from one clinic in India in 2010 to 500 clinics, across...
- Quadria Capital weighs Encube sale, keeps public float option alive, tooQuadria Capital is exploring options to sell its stake in Encube Ethicals. The healthcare investor considers both a controlling stake sale ...
- Asia Healthcare Holdings to invest Rs 400 crore in Asian Institute of Nephrology and Urology to double hospital networkAsia Healthcare Holdings will invest Rs 400 crore in Asian Institute of Nephrology and Urology. The investment will occur over the next 4-5...
- Dialysis chain NephroPlus eyes Rs 2,000 crore IPONephrocare Health Services, known as NephroPlus, is set to file its DRHP with SEBI by the end of this month, aiming to raise over ₹2,000 cr...
- Single speciality hospitals boom on strong demand, PE infusionIndia's single-specialty hospital market is projected to more than double to $31 billion in the next three to four years, driven by private...
- Does NSE's price capping on SME IPOs mean no multibagger returns on Day 1?As SME IPOs gain traction among investors, regulators are moving to formalise the market with stricter controls. The NSE recently imposed a...
- Nephro Care shares list at 90% premium on NSE SME platformNephro Care made a strong market debut on NSE SME platform with a 90% premium. The IPO garnered massive investor interest, oversubscribed b...
- Ambey Laboratories opens today: Check issue size, price band, GMP & other detailsAmbey Laboratories’ SME IPO, aiming to raise Rs 44.68 crore by July 8, offers shares at Rs 65-68 in lots of 2,000. With Rs 100 crore revenu...
- Deepak Parekh-backed Nephro Care's IPO GMP soars to 300% on allotment day. Here's how you can check statusDeepak Parekh-backed Nephro Care's IPO GMP soars to 300% on allotment day. Here's how you can check status
- Nephro Care IPO opens today: Check issue size, price band, GMP and other detailsInvest in the Nephro Care IPO in Kolkata to support healthcare initiatives and gain potential returns through shares.
- Nephro Care India IPO: Deepak Parekh-backed company to raise around Rs 40 crore via public issue on NSE EmergeDeepak Parekh-backed multi-speciality healthcare provider Nephro Care India Limited (NCIL) is likely to raise around Rs 40 crore through th...
- Nephro Care India files DRHP to raise funds via IPOAccording to the draft papers, the company’s initial public offering comprises a fresh issuance of 45,84,000 equity shares, each with a fac...
- Investcorp closes Rs 323-crore funding round in NephroPlusThe latest transaction will see Sea-Link Capital Partners, the investment firm founded by former KKR senior executive Heramb Hajarnavis, sc...
- How Kamal D Shah’s medical problem inspired NephroPlus, a pan-India kidney care centreEntrepreneurs are wont to fate as the trigger for their start-ups, but here it was sheer providence that Shah ended up as one of the co-fou...
- Five Indian start-ups made in economic slowdown & lessons they offerET is profiling five start-ups that have begun their lives during the ongoing tough times and shares lessons these intrepid companies have ...
- Five Indian start-ups made in economic slowdown & lessons they offerET is profiling five start-ups that have begun their lives during the ongoing tough times and shares lessons these intrepid companies have ...
- NephroPlus: A startup betting big on walk-in dialysis careWith a global recession underway, the timing for launching a startup might have seemed inopportune, but Vikram Vuppala and his fellow found...
- NephroPlus: A startup betting big on walk-in dialysis careWith a global recession underway, the timing for launching a startup might have seemed inopportune, but Vikram Vuppala and his fellow found...
Load More
